Cardiovascular Complications in Patients Hospitalized for COVID-19: A Cohort Study in Havana, Cuba

Luis Mariano de la Torre Fonseca1, Robert Alarcón Cedeño2, Víctor Alfonso Jiménez Díaz3

  • 1Intensive Care Unit, Comandante Manuel Fajardo Clinical-Surgical University Hospital, Habana, Cuba.

Insights

Older age and a history of ischemic heart disease are key predictors of cardiovascular complications in patients hospitalized with severe COVID-19, impacting survival rates.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 (Coronavirus Disease 2019) is associated with significant cardiovascular complications during hospitalization.
  • The specific risk factors for these complications remain incompletely understood.
  • Understanding these determinants is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the relationship between in-hospital cardiovascular complications and patients' pre-existing cardiovascular history.
  • To identify predictors of cardiovascular complications in patients admitted to the Intensive Care Unit (ICU) with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection.

Main Methods:

  • A prospective cohort study was conducted.
  • 373 patients diagnosed with SARS-CoV-2 and admitted to the ICU between March and October 2021 were included.
  • Data on cardiovascular history and hospital outcomes were collected.

Main Results:

  • 29.2% of patients experienced cardiovascular complications, including electrical disturbances (21.2%), acute coronary syndrome (5.9%), and pulmonary thromboembolism (1.9%).
  • Advanced age (Risk Ratio [RR]: 1.02) and a history of ischemic heart disease (RR: 2.23) were identified as independent predictors.
  • These predictors were significantly associated with increased risk of complications.

Conclusions:

  • Age and a history of ischemic heart disease are independent predictors of cardiovascular complications in severe COVID-19 patients.
  • These factors are significantly associated with poorer survival outcomes.
  • Further research is needed to elucidate the full spectrum of cardiovascular risk in COVID-19.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
28
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
328
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
22
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
31